Search results
Senior Consultant with the Department of Cardiology
- Clinical Associate Prof Chin Chee Tang is a Senior Consultant with the Department of Cardiology, and the Director of Coronary Intervention Service at the National Heart Centre Singapore (NHCS). His sub-specialty interest is in interventional cardiology and he performs percutaneous coronary interventions both in the elective and emergency settings.
www.duke-nus.edu.sg › directory › detail
People also ask
Who is Chin Chee Tang?
Who is Tan Ching Ngee?
Who is Tan Chee Meng?
Who is Dr Tan Cheng?
Asst Prof Chin Chee Tang is a Senior Consultant with the Department of Cardiology at the National Heart Centre Singapore (NHCS). His sub-specialty interest is in interventional cardiology.
Clinical Associate Prof Chin Chee Tang is a Senior Consultant with the Department of Cardiology, and the Director of Coronary Intervention Service at the National Heart Centre Singapore (NHCS).
Chee Tang CHIN | Cited by 1,382 | of National Heart Centre Singapore, Singapore (NHCS) | Read 83 publications | Contact Chee Tang CHIN
Curious about the risk factors of heart disease? Dr Chin Chee Tang and Dr Tang Hak Chiaw, Senior Consultants from the Department of Cardiology at Singapore General Hospital, give detailed answers to your questions.
Chee Tang Chin 1 , John C Messenger 2 , David Dai 3 , Lisa A McCoy 3 , Michael A Kutcher 4 , H Vernon Anderson 5 , Matthew T Roe 3 , Tracy Y Wang 3 Affiliations 1 Duke Clinical Research Institute, Durham, NC; National Heart Centre Singapore, Singapore.
- Chee Tang Chin, John C. Messenger, David Dai, Lisa A. McCoy, Michael A. Kutcher, H. Vernon Anderson,...
- 2014
Feb 21, 2017 · Dr Chin Chee Tang. Senior Consultant, Cardiology. National Heart Centre Singapore. Assistant Professor, Duke-NUS Medical School. Tags: Doctor, Medical Education. Faces of Healthcare. Tags: Internal, SingHealth, National Heart Centre Singapore, Article, Faces of Healthcare.
Chee Tang Chin's 6 research works with 47 citations and 350 reads, including: The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction.